By binding to the GLP-1 receptor, both drugs work to reduce food intake and increase insulin sensitivity. Tirzepatide is a dual agonist that targets both the GLP-1 and glucagon receptors, while Semaglutide is a single GLP-1 receptor agonist. You can speak to your doctor too to help evaluate the best option for you.